Advanced search

1116 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PureTech Health : Proxy Form for 2024 AGM	04-25	PU
PureTech Health : Notice of Meeting for 2024 AGM	04-25	PU
PureTech Announces Annual Results for Year Ended December 31, 2023	04-25	BU
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1	04-23	AQ
China's drugmakers can't sell mRNA shots but haven't quit yet	04-19	RE
Ceragon : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	04-18	PU
Moderna : 2024 Proxy Statement	04-16	PU
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board	01-26	AQ
Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases	01-04	AQ
Transcript : Mineral Resources Limited - Shareholder/Analyst Call	11-16
Transcript : Alexandria Real Estate Equities, Inc., Q3 2023 Earnings Call, Oct 24, 2023	24/10/23
MinRes Annual Reporting Suite: Legacy of Leadership	16/10/23	PU
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1	21/09/23	AQ
Théâtre l'Étoile Becomes Théâtre Manuvie	18/09/23	AQ
HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board	14/09/23	AQ
Ipsen : and Exicure enter into exclusive collaboration targeting rare neurodegenerative disorders	30/08/23	PU
PureTech Health plc – Half-Year Report	29/08/23	BU
Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings	09/08/23	AQ
Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems	11/07/23	AQ
Sigilon Therapeutics : Lilly to Acquire Sigilon Therapeutics - Form 8-K	29/06/23	PU
Lilly to Acquire Sigilon Therapeutics	29/06/23	PR
Dr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of Research	27/06/23	AQ
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women	21/06/23	AQ
DarÃ© Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women	21/06/23	CI
An affiliate of Blackstone Infrastructure Partners, L.P., a fund managed by Blackstone Inc. (NYSE:BX), entered into a definitive agreement to acquire a 19.9% equity interest in Northern Indiana Public Service Company, LLC from NiSource Inc. (NYSE:NI) for $2.2 billion.	19/06/23	CI
Results of PureTech's Annual General Meeting	13/06/23	BU
Quebec firm to pay $10M to avoid charges over bribes promised to Philippine officials	31/05/23	AQ
Sigilon Announces Reverse Stock Split of Common Stock	22/05/23	AQ
SIGILON THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	09/05/23	AQ
Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights	09/05/23	GL
PureTech Health : Notice of Meeting for 2023 AGM	28/04/23	PU
PureTech Health : Proxy Form for 2023 AGM	28/04/23	PU
PureTech Announces Annual Results for Year Ended December 31, 2022	28/04/23	BU
Daré Bioscience Announces Publication of Positive Safety and Acceptability Data from Phase 1 Clinical Trial that Support the Potential of DARE-HRT1 Intravaginal Ring as a New Menopausal Hormone Therapy	18/04/23	AQ
Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference	18/04/23	AQ
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights	14/03/23	AQ
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury	09/03/23	BU
Domtar Corporation completed the acquisition of Resolute Forest Products Inc. from Fairfax Financial Holdings Limited, Chou Associates Management Inc., Dimensional Fund Advisors LP and others.	28/02/23	CI
FREQUENCY THERAPEUTICS, INC. : Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	13/02/23	AQ
Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer	13/02/23	CI
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	26/01/23	AQ
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	26/01/23	CI
Transcript : Establishment Labs Holdings Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 07:30 AM	12/01/23
Daré Bioscience Announces Positive Pharmacokinetic (PK) Results from the DARE-HRT1 Phase 1 / 2 Study that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause	09/01/23	AQ
Daré Bioscience, Inc. Announces Positive Pharmacokinetic Results from the DARE-HRT1 Phase 1 / 2 Study	09/01/23	CI
Transcript : Sandfire Resources Limited - Shareholder/Analyst Call	30/11/22
SIGILON THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22	AQ
Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights	10/11/22	AQ
Establishment Labs : Third Quarter 2022 Results	08/11/22	PU
Transcript : Establishment Labs Holdings Inc., Q3 2022 Earnings Call, Nov 07, 2022	07/11/22

No results for this search

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer